Article
Research on CCR7, CD209 and CD19 as Novel Immune Markers for Prognosis of Cervical Cancer after Radiotherapy
2026-06-15
Abstract excerpt
<title>Abstract</title> <p>Background One of the most prevalent malignant neoplasms among women worldwide is Cervical cancer (CC). Radiotherapy is the primary treatment modality for this disease, yet its efficacy is contingent upon a multitude of factors. It is therefore imperative to identify reliable biomarkers for radiotherapy in the treatment of CC. Currently, there are still relatively few detection methods...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bc9cf7ba-3def-539d-90e4-2b2253d4b398
- DOI
- 10.21203/rs.3.rs-9906804/v1
